1Mullane KM,Kraemer R,Smith D et al.Myoperoxidase activity as a quanti-tative assessment of neutrophil infiltration Into ischemic myocardium. JPharmacol methods . 1975
2Takahiko N,Ueda M,haze K et sl.Neutrophil infiltration of culprit lessonsin acute coronary syndromes. Circulation . 2002
3Suglyama S,Okada Y,Sukhova GK et al.Macrophage myoperoxidase reg-ulation by granulocyte macrophage colony-stimulating factor in humanatherrosclerosis and implications in acute coronary syndromes. American Journal of Pathology . 2001
4Feld S,Li G,Wu A et al.Reduction of canlno infarct size by bolus intra-venous administration of liposomal prostaglandin E;comparison with con-trol. American Heart Journal . 1996
5Zhang R,Brennan ML,Fu X et al.Association between myoperoxidaselevels and risk of coronary artery disease. The Journal of The American Medical Association . 2001
6Buffon A,Blasucci LM,Luzzo G et al.Widespread coronary infiltration inunstable angma. The New England Journal of Medicine . 2002
7Naghavi m,Libby P,Falk E et al.From vulnerable plaque to vulnerablepatiept:a call for new definations andrisk assessment strategies. Circulation . 2003
8Baldus S,Heeschen C,Memertz T et al.myoperoxldase serum levelspredlcat rlsk in patlents with acute coronary syndromes. Clrclllatlon . 2003
9Brennan ML,Penlfl MS,Van Lente F et al.Prognostic value of myopc-Foxidase in Pattents with chcst Pain. N Enel J Mcd . 2003
10Blasucci LM,D’onofrio G,luzzo G et al.Intracellular neutroPhil my-operoxidase in reduccd in unstable angian and acute myocardial infarctionbut its reduction is not related to ischemia. Journal of the American College of Cardiology . 1996
